GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Revvity Inc (NYSE:RVTY) » Definitions » E10

Revvity (Revvity) E10 : $4.23 (As of Mar. 2024)


View and export this data going back to 1983. Start your Free Trial

What is Revvity E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Revvity's adjusted earnings per share data for the three months ended in Mar. 2024 was $0.210. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $4.23 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 24.60% per year. During the past 5 years, the average E10 Growth Rate was 21.60% per year. During the past 10 years, the average E10 Growth Rate was 12.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Revvity was 25.40% per year. The lowest was -10.50% per year. And the median was 7.25% per year.

As of today (2024-05-02), Revvity's current stock price is $101.08. Revvity's E10 for the quarter that ended in Mar. 2024 was $4.23. Revvity's Shiller PE Ratio of today is 23.90.

During the past 13 years, the highest Shiller PE Ratio of Revvity was 72.95. The lowest was 19.79. And the median was 38.70.


Revvity E10 Historical Data

The historical data trend for Revvity's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revvity E10 Chart

Revvity Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.90 2.19 3.16 3.75 4.24

Revvity Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.23 4.27 4.27 4.24 4.23

Competitive Comparison of Revvity's E10

For the Diagnostics & Research subindustry, Revvity's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revvity's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Revvity's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Revvity's Shiller PE Ratio falls into.



Revvity E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Revvity's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.21/129.4194*129.4194
=0.210

Current CPI (Mar. 2024) = 129.4194.

Revvity Quarterly Data

per share eps CPI Adj_EPS
201406 0.440 100.560 0.566
201409 0.370 100.428 0.477
201412 0.270 99.070 0.353
201503 0.360 99.621 0.468
201506 0.430 100.684 0.553
201509 0.480 100.392 0.619
201512 0.610 99.792 0.791
201603 0.430 100.470 0.554
201606 0.580 101.688 0.738
201609 0.530 101.861 0.673
201612 0.590 101.863 0.750
201703 0.350 102.862 0.440
201706 1.840 103.349 2.304
201709 0.820 104.136 1.019
201712 -0.373 104.011 -0.464
201803 0.230 105.290 0.283
201806 0.570 106.317 0.694
201809 0.690 106.507 0.838
201812 0.640 105.998 0.781
201903 0.320 107.251 0.386
201906 0.620 108.070 0.742
201909 0.520 108.329 0.621
201912 0.580 108.420 0.692
202003 0.300 108.902 0.357
202006 1.230 108.767 1.464
202009 1.570 109.815 1.850
202012 3.380 109.897 3.980
202103 3.370 111.754 3.903
202106 2.190 114.631 2.473
202109 1.110 115.734 1.241
202112 1.410 117.630 1.551
202203 1.400 121.301 1.494
202206 1.420 125.017 1.470
202209 0.670 125.227 0.692
202212 1.090 125.222 1.127
202303 4.500 127.348 4.573
202306 0.280 128.729 0.282
202309 0.080 129.860 0.080
202312 0.637 129.419 0.637
202403 0.210 129.419 0.210

Add all the adjusted EPS together and divide 10 will get our e10.


Revvity  (NYSE:RVTY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Revvity's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=101.08/4.23
=23.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Revvity was 72.95. The lowest was 19.79. And the median was 38.70.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Revvity E10 Related Terms

Thank you for viewing the detailed overview of Revvity's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Revvity (Revvity) Business Description

Traded in Other Exchanges
Address
940 Winter Street, Waltham, MA, USA, 02451
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
Executives
Anita Gonzales officer: Please See Remarks 940 WINTER STREET, REVVITY, WALTHAM MA 02451-1457
Andrew Okun officer: Please See Remarks 940 WINTER STREET, PERKINELMER, WALTHAM MA 02451
Maxwell Krakowiak officer: Please See Remarks 940 WINTER STREET, PERKINELMER, WALTHAM MA 02451-1457
Daniel R Tereau officer: Please See Remarks 940 WINTER STREET, PERKINELMER, WALTHAM MA 02451
Tajinder Vohra officer: Please See Remarks 940 WINTER STREET, WALTHAM MA 02451-1457
Prahlad R. Singh officer: Please See Remarks 940 WINTER STREET, PERKINELMER, WALTHAM MA 024511457
Joel S Goldberg officer: See Remarks 940 WINTER STREET, WALTHAM MA 02451
Michelle Mcmurry-heath director C/O BIOVENTUS INC., 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM NC 27703
James M Mock officer: Please See Remarks 940 WINTER STREET, PERKINELMER, WALTHAM MA 02451
Sylvie Gregoire director 940 WINTER STREET, C/O PERKINELMER, WALTHAM MA 02451
Miriame Victor officer: Please See Remarks 940 WINTER STREET, PERKINELMER, WALTHAM MA 02451-1457
Peter Barrett director C/O ALNYLAM PHARMACEUTICALS, INC., 300 THIRD STREET, CAMBRIDGE MA 02142
Michel Vounatsos director BIOGEN INC., 225 BINNEY ST., CAMBRIDGE MA 02142
Alexis P Michas director 940 WINTER STREET, C/O PERKINELMER, WALTHAM MA 02451
Pascale Witz director C/O REGULUS THERAPEUTICS INC., 10614 SCIENCE CENTER DRIVE, SAN DIEGO CA 92121

Revvity (Revvity) Headlines

From GuruFocus

Q3 2021 PerkinElmer Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Revvity Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Q3 2023 Revvity Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2021 PerkinElmer Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Revvity Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024